Eolas Therapeutics, Inc.
Eolas is developing a much safer and more efficacious smoking cessation drug by specifically targeting the addiction motivation pathway.
Eolas Therapeutics is a therapeutic development company with lead programs to treat nicotine and other drug addictions. The healthcare and cost benefits to smoking cessation alone are massive, but current treatments are ineffective. EORA101 is a first-in-class drug that specifically interferes with addiction motivation rather than individual drug signaling pathways. This targeting strategy can yield a much safer and more effective treatment.